4.7 Article

VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses

期刊

JOURNAL OF EXPERIMENTAL MEDICINE
卷 208, 期 3, 页码 577-592

出版社

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20100619

关键词

-

资金

  1. National Institutes of Health [A1048667-06A1, 5R01A1007289, 1U01GM094665, 1U54GM094662]
  2. MRC [G0802651] Funding Source: UKRI
  3. Medical Research Council [G0802651, G0600698B] Funding Source: researchfish

向作者/读者索取更多资源

The immunoglobulin (Ig) superfamily consists of many critical immune regulators, including the B7 family ligands and receptors. In this study, we identify a novel and structurally distinct Ig superfamily inhibitory ligand, whose extracellular domain bears homology to the B7 family ligand PD-L1. This molecule is designated V-domain Ig suppressor of T cell activation (VISTA). VISTA is primarily expressed on hematopoietic cells, and VISTA expression is highly regulated on myeloid antigen-presenting cells (APCs) and T cells. A soluble VISTA-Ig fusion protein or VISTA expression on APCs inhibits T cell proliferation and cytokine production in vitro. A VISTA-specific monoclonal antibody interferes with VISTA-induced suppression of T cell responses by VISTA-expressing APCs in vitro. Furthermore, anti-VISTA treatment exacerbates the development of the T cell-mediated autoimmune disease experimental autoimmune encephalomyelitis in mice. Finally, VISTA overexpression on tumor cells interferes with protective antitumor immunity in vivo in mice. These findings show that VISTA, a novel immunoregulatory molecule, has functional activities that are nonredundant with other Ig superfamily members and may play a role in the development of autoimmunity and immune surveillance in cancer.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据